The Rundown cover image

Buffett Buys Google, Novo Nordisk Cuts Obesity Drug Prices, and Public Launches AI Brokerage

The Rundown

00:00

Novo Nordisk's Challenging Year

Zaid summarizes Novo's downgraded forecasts and the stock's large pullback amid competitive pressures.

Play episode from 04:31
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app